|
|
 |
 |
Search Results for: D |
 |
|
 |
|
|
 |
| 46 |
3-(Dimethylamino)-2-methyl-2-propenal
Manus Aktteva offers 3-(Dimethylamino)-2-methyl-2-propenal, 19125-76-9, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 47 |
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride
Manus Aktteva offers Ondansetron Intermediate, Mannich Base HCL, also known as 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride, 119812-29-2, for your evaluation,pilots and commercial requirements with supportive ....
View Detail
|
 |
|
|
| 48 |
3-Dimethyl amino-1-(2-thienyl)-1-propanone hydrochloride
Manus Aktteva offers Duloxetine intermediate, 3-Dimethyl amino-1-(2-thienyl)-1-propanone hydrochloride, 5424-47-5, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 49 |
3-Dimethylaminopropylchloride hydrochloride
Manus Aktteva offers 5407-04-5, Intermediate of Olopatadine hydrochloride, 3-Dimethylamino propylchloride hydrochloride, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation f....
View Detail
|
 |
|
|
| 50 |
4,5-Dimethoxy-2-nitrobenzoic acid
Manus Aktteva offers 4,5-Dimethoxy-2-nitrobenzoic acid, 2-Nitro-4,5-dimethoxy-benzoic acid, 6-Nitroveratric acid, having a cas no 4998-07-6, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package requi....
View Detail
|
 |
|
|
| 51 |
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
Manus Aktteva offers Bosentan Intermediate, 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine, 150728-13-5, , for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 52 |
4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride
Manus Aktteva offers Racemic Sertraline hydrochloride, 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride, 79617-89-3, for your evaluation,pilots and commercial requirements with supportive technical package required f....
View Detail
|
 |
|
|
| 53 |
4-(3-(dibutylamino)propoxy)benzoic acid hydrochloride
Manus Aktteva offers 4-(3-(dibutylamino)propoxy)benzoic acid hydrochloride having cas no 437651-44-0 which is a Dronedarone Intermediate for your evaluation with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 54 |
4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile
Manus Aktteva offers 103146-25-4, Diol base, Intermediate of Citalopram, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 55 |
4-[4-Dimethyl amino)-1-(4’-fluoro phenyl)-1-hydroxybutyl-3-(hydroxy Methyl)-benzonitrile hydro bromide
Manus Aktteva offers Escitalopram Intermediate, 4-[4-Dimethyl amino)-1-(4’-fluoro phenyl)-1-hydroxybutyl-3-(hydroxy Methyl)-benzonitrile hydro bromide, 103146-26-5, for your evaluation, pilots and commercial requirements with supportive technical pac....
View Detail
|
 |
|
|
| 56 |
5,6-Dichloronicotinic acid
Manus Aktteva offers 41667-95-2, 5,6-Dichloronicotinic acid, 5,6-Dichloropyridine-3-carboxylic acid,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 57 |
5,6-Dimethoxy-1-indanone
Manus Aktteva offers Donepezil Intermediate, 5,6-Dimethoxy-1-indanone, 2107-69-9,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 58 |
6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid
Manus Aktteva offers Olopatadine intermediates, including 6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid, having a cas no 55453-87-7,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required ....
View Detail
|
 |
|
|
| 59 |
6,7-Dihydro-6-mercapto-5H-pyrazolo[1,2-a][1,2,4]triazolium chloride
Manus Aktteva offers Biapenem, Side Chain, Intermediate, having cas no 2153851-71-9, 6,7-Dihydro-6-mercapto-5H-pyrazolo[1,2-a][1,2,4]triazolium chloride, for your requirements of RND, evaluation, pilots and commercial along with supportive technical....
View Detail
|
 |
|
|
| 60 |
6,7-Dimethoxyquinazoline-2,4-dione
Manus Aktteva offers 6,7-Dimethoxyquinazoline-2,4-dione, 28888-44-0,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|